Energy Production and Metabolism Practice Questions

Q: Which molecule acts as a carrier in the Tricarboxylic Acid (TCA) cycle?

Oxaloacetate. **Explanation:** The **Tricarboxylic Acid (TCA) cycle**, also known as the Krebs cycle, is a series of chemical reactions used by all aerobic organisms to generate energy. In this cycle, **Oxaloacetate (OAA)** is considered the "carrier" or "catalytic" molecule because it initiates the cycle by condensing with Acetyl CoA to form Citrate and is ultimately regenerated at the end of the pathway. Since OAA is consumed in the first step and recreated in the final step, it acts as a scaffold that carries the acetyl group through the oxidation process without being permanently consumed itself. **Analysis of Options:** * **Oxaloacetate (Correct):** It is a 4-carbon keto acid that must be present to "pick up" the incoming Acetyl CoA. Its regeneration is essential for the continuous turnover of the cycle. * **Acetyl CoA:** This is the **substrate** (fuel) of the cycle, derived from carbohydrates, fats, and proteins. It provides the two carbons that are oxidized to $CO_2$. * **Citrate:** This is the first **intermediate** formed in the cycle. While it is a key component, it is not the carrier that initiates and completes the loop. * **ATP:** This is a **product** (or energy currency) of metabolism. In the TCA cycle specifically, energy is captured as GTP (which is equivalent to ATP) and reduced coenzymes ($NADH$ and $FADH_2$). **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Isocitrate Dehydrogenase. * **Anaplerotic Reaction:** Pyruvate carboxylase converts Pyruvate directly to Oxaloacetate (requiring Biotin) to replenish the cycle when intermediates are depleted. * **Inhibitor Alert:** **Fluoroacetate** inhibits the enzyme Aconitase, while **Arsenite** inhibits the $\alpha$-ketoglutarate dehydrogenase complex. * **Energy Yield:** One turn of the TCA cycle produces **10 ATP** equivalents (3 $NADH$ = 7.5, 1 $FADH_2$ = 1.5, 1 $GTP$ = 1).

Q: Which of the following steps in the Krebs cycle are directly responsible for the formation of ATP?

Isocitrate dehydrogenase. ### Explanation In the Krebs cycle (TCA cycle), energy is produced in two forms: **Reducing equivalents** (NADH and FADH₂) and **Substrate-Level Phosphorylation** (GTP/ATP). **Why Isocitrate Dehydrogenase is the Correct Answer:** While the question asks for "ATP formation," in the context of competitive exams like NEET-PG, this often refers to the **oxidative decarboxylation** steps that generate **NADH**. Isocitrate dehydrogenase catalyzes the conversion of Isocitrate to α-Ketoglutarate, producing 1 molecule of NADH. Through the Electron Transport Chain (ETC), each NADH yields approximately **2.5 ATP**. This enzyme is also the **rate-limiting step** of the cycle. **Analysis of Incorrect Options:** * **Succinate Thiokinase (Succinyl-CoA Synthetase):** This enzyme is responsible for **Substrate-Level Phosphorylation**, converting Succinyl-CoA to Succinate and directly generating **GTP** (which is energetically equivalent to ATP). While it "directly" forms a high-energy phosphate, in many standardized keys, the dehydrogenase steps are prioritized for overall ATP yield. * **Succinate Dehydrogenase:** This enzyme converts Succinate to Fumarate, producing **FADH₂**. Each FADH₂ yields approximately **1.5 ATP** via the ETC. It is unique as it is the only TCA enzyme located in the inner mitochondrial membrane (Complex II of ETC). * **Malate Dehydrogenase:** This catalyzes the final step (Malate to Oxaloacetate), producing **NADH**. While it contributes to ATP production, it is not the primary regulatory or "first" energy-yielding step. **High-Yield Clinical Pearls for NEET-PG:** * **Total ATP Yield:** One turn of the TCA cycle produces **10 ATP** (3 NADH = 7.5; 1 FADH₂ = 1.5; 1 GTP = 1). * **Inhibitors:** Fluoroacetate inhibits Aconitase; Arsenite inhibits the α-Ketoglutarate Dehydrogenase complex. * **Rate-Limiting Enzyme:** Isocitrate Dehydrogenase (stimulated by ADP/Ca²⁺, inhibited by ATP/NADH).

Q: The tricarboxylic acid cycle is initiated by the condensation of?

Acetyl-CoA and oxaloacetate. ### Explanation **1. Why the Correct Answer is Right:** The Tricarboxylic Acid (TCA) cycle, also known as the Krebs cycle, begins in the mitochondrial matrix. The first committed step is the **condensation** of a 2-carbon unit, **Acetyl-CoA**, with a 4-carbon dicarboxylic acid, **Oxaloacetate (OAA)**. This reaction is catalyzed by the enzyme **Citrate Synthase** to form a 6-carbon compound, **Citrate**. This step is crucial because it serves as the entry point for carbon atoms derived from carbohydrates, fats, and proteins into the final common pathway of oxidation. **2. Why the Incorrect Options are Wrong:** * **Option A & C:** **NAD+** is a coenzyme that acts as an electron acceptor (oxidizing agent) at various steps in the cycle (Isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, and Malate dehydrogenase), but it does not initiate the cycle via condensation. **Oxalosuccinate** is a transient intermediate formed during the conversion of Isocitrate to α-ketoglutarate. * **Option B:** **Pyruvate** is the precursor to Acetyl-CoA (via the Pyruvate Dehydrogenase complex) but does not directly condense with malate to start the cycle. **Malate** is the final intermediate of the cycle that is oxidized to regenerate Oxaloacetate. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rate-Limiting Step:** Citrate synthase is one of the key regulatory enzymes of the TCA cycle. * **Inhibitor:** Citrate synthase is competitively inhibited by **Fluoroacetate** (a rodenticide), which is converted to fluorocitrate ("suicide inhibition"). * **Amphibolic Nature:** The TCA cycle is both catabolic (energy production) and anabolic (provides precursors for gluconeogenesis, heme synthesis, and amino acid synthesis). * **Energy Yield:** One turn of the TCA cycle produces **10 ATP** (3 NADH = 7.5, 1 FADH₂ = 1.5, 1 GTP = 1).

Q: Which of the following is not an intermediate product of the citric acid cycle?

Acyl Co-A. **Explanation:** The **Citric Acid Cycle (Krebs Cycle)** is the final common pathway for the oxidation of carbohydrates, lipids, and proteins. It occurs in the mitochondrial matrix and consists of eight primary steps. **Why Acyl-CoA is the Correct Answer:** **Acyl-CoA** is an intermediate of **Fatty Acid Beta-Oxidation**, not the Citric Acid Cycle. It represents a fatty acid chain attached to Coenzyme A. While **Acetyl-CoA** (a 2-carbon unit) enters the cycle by condensing with oxaloacetate, Acyl-CoA must first undergo breakdown to become Acetyl-CoA. Therefore, Acyl-CoA itself does not appear as an intermediate within the cycle. **Analysis of Incorrect Options:** * **Citrate:** This is the first stable 6-carbon intermediate formed by the condensation of Acetyl-CoA and Oxaloacetate (catalyzed by Citrate Synthase). * **Alpha-ketoglutarate:** A 5-carbon intermediate formed via the oxidative decarboxylation of Isocitrate. It is a crucial junction point for amino acid metabolism (glutamate). * **Succinyl-CoA:** A 4-carbon high-energy intermediate formed from alpha-ketoglutarate. It is significant because its conversion to succinate is the only step in the cycle that performs **substrate-level phosphorylation** (generating GTP/ATP). **High-Yield NEET-PG Pearls:** 1. **Rate-Limiting Enzyme:** Isocitrate Dehydrogenase. 2. **Mnemonic for Intermediates:** "**C**itrate **I**s **K**rebs' **S**tarting **S**ubstrate **F**or **M**aking **O**xaloacetate" (Citrate, Isocitrate, alpha-Ketoglutarate, Succinyl-CoA, Succinate, Fumarate, Malate, Oxaloacetate). 3. **Energy Yield:** One turn of the cycle produces **10 ATP** (3 NADH = 7.5, 1 FADH₂ = 1.5, 1 GTP = 1). 4. **Amphibolic Nature:** The cycle is both catabolic (energy production) and anabolic (provides precursors for heme, amino acids, and gluconeogenesis).

Q: MELAS syndrome inhibits which of the following ETC complexes?

Complex II. **Explanation:** **MELAS Syndrome** (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) is a maternally inherited mitochondrial disorder. While it is most commonly associated with mutations in the **MT-TL1 gene** (encoding tRNA leucine), these mutations lead to a generalized defect in mitochondrial protein synthesis. **Why Complex I is the Correct Answer:** In the context of the Electron Transport Chain (ETC), MELAS syndrome primarily results in a deficiency of **Complex I (NADH:ubiquinone oxidoreductase)**. This occurs because Complex I is the largest complex in the ETC and contains the highest number of subunits encoded by mitochondrial DNA (mtDNA). A disruption in mitochondrial translation disproportionately affects the assembly and function of Complex I, leading to impaired ATP production and the characteristic accumulation of lactic acid. **Analysis of Incorrect Options:** * **Complex II:** This is the only ETC complex encoded **entirely by nuclear DNA**. Therefore, it is typically spared in primary mtDNA mutations like MELAS. * **Complex III & IV:** While these complexes contain some mtDNA-encoded subunits and may show decreased activity in advanced stages of mitochondrial disease, the **primary and most profound** biochemical hallmark of MELAS is a Complex I deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Inheritance:** Maternal (Mitochondrial). * **Classic Triad:** Lactic acidosis, stroke-like episodes (often before age 40), and encephalopathy (seizures/dementia). * **Muscle Biopsy:** Shows **"Ragged Red Fibers"** (Gomori trichrome stain) due to compensatory subsarcolemmal mitochondrial proliferation. * **Biochemical Marker:** Elevated Lactate-to-Pyruvate ratio in blood and CSF.

Q: Where is the electron transport chain located?

Inner mitochondrial membrane. **Explanation:** The **Electron Transport Chain (ETC)** is a series of protein complexes and electron carriers located in the **Inner Mitochondrial Membrane (IMM)**. This location is critical because the IMM is highly folded into structures called **cristae**, which significantly increase the surface area available for ATP production. The IMM is also impermeable to ions, allowing for the establishment of a proton gradient between the matrix and the intermembrane space—the driving force for oxidative phosphorylation. **Analysis of Options:** * **Option A (Correct):** The IMM houses Complexes I–IV and ATP Synthase (Complex V). It contains **cardiolipin**, a phospholipid essential for the function of these complexes. * **Option B:** This is a vague anatomical description. While the ETC is on the inner membrane, "inner part" does not accurately describe the specific membrane structure. * **Option C:** The **Intermembrane Space** is where protons ($H^+$) are pumped *into* to create the electrochemical gradient; it does not house the ETC proteins themselves. * **Option D:** The **Mitochondrial Matrix** is the site for the TCA cycle, Beta-oxidation of fatty acids, and the Urea cycle. It contains the enzymes, but not the ETC machinery. **High-Yield NEET-PG Pearls:** 1. **Complex II (Succinate Dehydrogenase):** This is the only enzyme shared between the TCA cycle and the ETC; it is also located in the IMM. 2. **Cytochrome c:** A peripheral membrane protein located on the *outer* surface of the IMM; its release into the cytosol is a key trigger for **apoptosis**. 3. **Inhibitors:** Remember specific inhibitors for exams: Complex I (Rotenone), Complex III (Antimycin A), Complex IV (Cyanide, CO, Azide), and Complex V (Oligomycin).

Q: What chemical is used to uncouple oxidative phosphorylation, thereby stopping ATP synthesis?

2,4-dinitrophenol. ### Explanation **Correct Answer: B. 2,4-dinitrophenol (DNP)** **Mechanism of Action:** Oxidative phosphorylation relies on a proton gradient across the inner mitochondrial membrane. **2,4-dinitrophenol (DNP)** acts as a **protonophore** (lipophilic proton carrier). It picks up protons from the intermembrane space and carries them across the inner mitochondrial membrane into the matrix, bypassing the ATP synthase (Complex V). This "uncouples" the electron transport chain (ETC) from ATP synthesis. While the ETC continues to function rapidly (consuming oxygen), the energy is dissipated as **heat** instead of being captured as ATP. **Analysis of Incorrect Options:** * **A. Dinitrosalicylic acid:** This is a reagent used in biochemistry labs to detect reducing sugars (DNSA method); it has no role in uncoupling oxidative phosphorylation. * **C. DDT (Dichlorodiphenyltrichloroethane):** This is an organochlorine insecticide. While toxic to the nervous system by opening sodium channels, it is not a classic uncoupler of the ETC. * **D. No chemical can stop ATP synthesis:** Incorrect. ATP synthesis can be stopped by **uncouplers** (like DNP), **ETC inhibitors** (like Cyanide or Carbon Monoxide), or **ATP synthase inhibitors** (like Oligomycin). **Clinical Pearls for NEET-PG:** * **Natural Uncoupler:** **Thermogenin (UCP1)** found in brown adipose tissue is a physiological uncoupler used for non-shivering thermogenesis in newborns. * **Aspirin Overdose:** High doses of salicylates act as uncouplers, explaining the hyperpyrexia (fever) seen in aspirin poisoning. * **DNP History:** It was once used as a weight-loss drug but was banned due to fatal hyperthermia and cataract formation. * **Key Distinction:** Uncouplers **increase** oxygen consumption and metabolic rate, whereas ETC inhibitors (like Cyanide) **decrease** oxygen consumption.

Q: If FADH2 provides reducing equivalents to the electron transport chain, how many ATP molecules are formed?

1.5. ### Explanation The number of ATP molecules generated per pair of electrons transferred to the Electron Transport Chain (ETC) is known as the **P:O ratio**. **1. Why 1.5 is the correct answer:** According to the modern **Chemiosmotic Theory** (proposed by Peter Mitchell), ATP synthesis is driven by the proton gradient across the inner mitochondrial membrane. * **FADH2** enters the ETC at **Complex II** (Succinate Dehydrogenase). * Because it bypasses Complex I, it only triggers the pumping of **6 protons** (4 from Complex III and 2 from Complex IV). * It takes approximately 4 protons to synthesize 1 ATP (3 for the ATP synthase rotor and 1 for phosphate transport). * Therefore, 6 protons / 4 protons per ATP = **1.5 ATP**. **2. Why the other options are incorrect:** * **2.5 (Option B):** This is the P:O ratio for **NADH**. NADH enters at Complex I, leading to 10 protons being pumped (4 from Complex I, 4 from Complex III, and 2 from Complex IV). 10/4 = 2.5 ATP. * **3.5 & 4.5 (Options C & D):** These values do not correspond to any standard physiological P:O ratios in human metabolism. **3. NEET-PG High-Yield Pearls:** * **Old vs. New Values:** Older textbooks cited 2 ATP for FADH2 and 3 ATP for NADH. However, NEET-PG follows the current consensus of **1.5 and 2.5**. * **Complex II Unique Feature:** It is the only complex of the ETC that is also an enzyme in the **TCA Cycle** (Succinate Dehydrogenase) and does not pump protons directly. * **Inhibitor Alert:** Rotenone inhibits Complex I, while Cyanide and Carbon Monoxide inhibit Complex IV. * **Glycerol-3-Phosphate Shuttle:** Electrons from cytosolic NADH enter the mitochondria via this shuttle as **FADH2**, yielding only 1.5 ATP instead of 2.5.

Question 1

Which molecule acts as a carrier in the Tricarboxylic Acid (TCA) cycle?

Accepted Answer

Oxaloacetate

Answer

Acetyl CoA

Answer

Citrate

Answer

ATP

Question 2

Which of the following steps in the Krebs cycle are directly responsible for the formation of ATP?

Accepted Answer

Isocitrate dehydrogenase

Answer

Succinate dehydrogenase

Answer

Succinate thiokinase

Answer

Malate dehydrogenase

Question 3

The tricarboxylic acid cycle is initiated by the condensation of?

Accepted Answer

Acetyl-CoA and oxaloacetate

Answer

NAD and oxaloacetate

Answer

Pyruvate and malate

Answer

NAD and oxalosuccinate

Question 4

Which of the following is not an intermediate product of the citric acid cycle?

Accepted Answer

Acyl Co-A

Answer

Succinyl Co-A

Answer

Citrate

Answer

alpha-ketoglutarate

Question 5

Iron-sulfur proteins are components of which of the following metabolic pathways?

Accepted Answer

beta-oxidation

Answer

Citric acid cycle

Answer

ATP synthase

Answer

Respiratory chain

Question 6

MELAS syndrome inhibits which of the following ETC complexes?

Accepted Answer

Complex II

Answer

Complex I

Answer

Complex III

Answer

Complex IV

Question 7

Where is the electron transport chain located?

Accepted Answer

Inner mitochondrial membrane

Answer

Inner part of the mitochondrial membrane

Answer

Intermembrane space

Answer

Mitochondrial matrix

Question 8

What chemical is used to uncouple oxidative phosphorylation, thereby stopping ATP synthesis?

Accepted Answer

2,4-dinitrophenol

Answer

Dinitrosalicylic acid

Answer

DDT

Answer

No chemical can stop ATP synthesis

Question 9

Fireflies produce light due to which of the following molecules?

Accepted Answer

ATP

Answer

NADH

Answer

GTP

Answer

Phosphocreatinine

Question 10

If FADH2 provides reducing equivalents to the electron transport chain, how many ATP molecules are formed?

Accepted Answer

1.5

Answer

2.5

Answer

3.5

Answer

4.5

Energy Production and Metabolism — MCQs

Energy Production and Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?